Surgery Story

SGRY -- USA Stock

USD 44.06 1.74 3.80%

Macroaxis Story

Surgery Partners is scheduled to announce its earnings today. The next earnings report is expected on the 10th of May 2021. Surgery Partners Total Assets Per Share are fairly stable at the moment as compared to the past year. Surgery Partners reported Total Assets Per Share of 117.08 in 2020. Quick Ratio is likely to rise to 1.44 in 2021, whereas Net Income Per Employee is likely to drop (9.7 K) in 2021. While many traders are getting carried away by overanalyzing healthcare space, it is reasonable to break down Surgery Partners CS as an investment alternative.

Published over a month ago

View all stories for Surgery Partners | View All Stories

Chances of Surgery (NASDAQ:SGRY) to slide in April

The company currently holds 3.23 B in liabilities with Debt to Equity (D/E) ratio of 2.11, implying Surgery Partners greatly relies on financing operations through barrowing. Surgery Partners has a current ratio of 1.48, which is within standard range for the sector.

Surgery Partners financial leverage ratio helps determine the effect of debt on the overall profitability of the company. It measures the total debt position of Surgery Partners, including all of Surgery Partners's outstanding debt obligations, and compares it with the equity. In simple terms, the high financial leverage means the cost of production, together with running the business day-to-day, is high, whereas, lower financial leverage implies lower fixed cost investment in the business and generally considered by investors to be a good sign. So if creditors own a majority of Surgery Partners assets, the company is considered highly leveraged. Understanding the composition and structure of overall Surgery Partners debt and outstanding corporate bonds gives a good idea of how risky the capital structure of a business is and if it is worth investing in it.

Please read more on our technical analysis page.

Understanding Surgery Total Debt

Surgery Partners liabilities are broken down into two parts on the balance sheet. These are short-term (or current) obligations and long-term debt. Surgery Partners has to fulfill its short-term liabilities in this reporting year and should be no more than 12 months old. Long-term debt, on the other hand, is anything beyond the 12-month payment timeframe. Common short-term liabilities found on Surgery Partners balance sheet include debt obligations and money owed to different Surgery Partners vendors, workers, and loan providers. Below is the chart of Surgery main long-term debt accounts currently reported on its balance sheet.

You can use Surgery Partners CS financial leverage analysis tool to get a better grip on understanding its financial position

How important is Surgery Partners's Liquidity

Surgery Partners financial leverage refers to using borrowed capital as a funding source to finance Surgery Partners CS ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Surgery Partners financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Surgery Partners's total debt and its cash.

Payment of 1934 shares by Thomas Cowhey of Surgery Partners subject to Rule 16b-3

Legal trades by Surgery Partners insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:

Surgery insider trading alert for payment of common stock by Thomas Cowhey, Chief Financial Officer, on 2nd of April 2021. This event was filed by Surgery Partners Inc with SEC on 2021-04-02. Statement of changes in beneficial ownership - SEC Form 4. Thomas Cowhey currently serves as cfo, principal accounting officer of Surgery Partners [view details]

Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

A Deeper Perspective

The entity reported the previous year's revenue of 1.83 B. Net Loss for the year was (179.3 M) with profit before overhead, payroll, taxes, and interest of 423.8 M.

Liabilities Breakdown

285 M

Current Liabilities

1.3 B

Long-Term Liabilities

	Total Liabilities	3.19 Billion
	Current Liabilities	284.95 Million
	Long-Term Liabilities	1.27 Billion
	Tax Liabilities	90.01 Million

Over 3 percent rise for Surgery Partners. What does it mean for investors?

Current maximum drawdown is at 29.18. Surgery Partners CS shows above-average downside volatility for the selected time horizon. We advise investors to inspect Surgery Partners CS further and ensure that all market timing and asset allocation strategies are consistent with the estimation of Surgery Partners future alpha. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Surgery Partners' stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Surgery Partners' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Our Conclusion on Surgery Partners

While other companies within the medical care facilities industry are still a little expensive, even after the recent corrections, Surgery Partners may offer a potential longer-term growth to investors. With a somewhat neutral outlook on your 30 days horizon, it may be better to hold off any trading activity and neither buy new shares of Surgery nor drop your existing holdings in the Stock. It seems the expected volatility has not yet been fully factored into the current price. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Surgery Partners.

About Contributor

Raphi Shpitalnik is a Junior Member of Macroaxs Editorial Board. Raphael is a young entrepreneur who joined Macroaxis on a part-time base at the beginning of the pandemic and eventually acquired a real test for investing and fintech. He likes to analyze different equity instruments across a wide range of industries, focusing primarily on consumer products, sports, fintech, cannabis, and AI. View Profile

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Surgery Partners CS. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2021 Macroaxis LLC